These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 18467676)

  • 1. Pharmacological effects of nicotine on norepinephrine metabolism in rat brown adipose tissue: relevance to nicotinic therapies for smoking cessation.
    Brees DJ; Elwell MR; Tingley FD; Sands SB; Jakowski AB; Shen AC; Cai JH; Finkelstein MB
    Toxicol Pathol; 2008 Jun; 36(4):568-75. PubMed ID: 18467676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK; Sumithran SP; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of brain and behavioral effects of varenicline and nicotine in rats.
    King J; Huang W; Chen W; Heffernan M; Shields J; Rane P; Bircher R; DiFranza JR
    Behav Brain Res; 2011 Sep; 223(1):42-7. PubMed ID: 21527291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of acetaldehyde on nicotine-induced transmitter levels in young and adult brain areas.
    Sershen H; Shearman E; Fallon S; Chakraborty G; Smiley J; Lajtha A
    Brain Res Bull; 2009 Aug; 79(6):458-62. PubMed ID: 19389462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine suppresses energy storage through activation of sympathetic outflow to brown adipose tissue via corticotropin-releasing factor type 1 receptor.
    Mano-Otagiri A; Iwasaki-Sekino A; Ohata H; Arai K; Shibasaki T
    Neurosci Lett; 2009 May; 455(1):26-9. PubMed ID: 19429100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and functional actions of tofacitinib related to the pathophysiology of hibernoma development.
    Radi ZA; Vogel WM; Bartholomew PM; Koza-Taylor P; Papanikolaou A; Wisialowski T; Nambiar P; Ball DJ
    Regul Toxicol Pharmacol; 2017 Dec; 91():93-102. PubMed ID: 29074274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
    Paterson NE; Min W; Hackett A; Lowe D; Hanania T; Caldarone B; Ghavami A
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1455-64. PubMed ID: 20708056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats.
    Levin ED; Rezvani AH; Xiao Y; Slade S; Cauley M; Wells C; Hampton D; Petro A; Rose JE; Brown ML; Paige MA; McDowell BE; Kellar KJ
    J Pharmacol Exp Ther; 2010 Mar; 332(3):933-9. PubMed ID: 20007754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two week nicotine treatment selectively increases bone vascular constriction in response to norepinephrine.
    Feitelson JB; Rowell PP; Roberts CS; Fleming JT
    J Orthop Res; 2003 May; 21(3):497-502. PubMed ID: 12706023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma.
    Radi Z; Bartholomew P; Elwell M; Vogel WM
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):456-63. PubMed ID: 24141031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased norepinephrine turnover rate in the brown adipose tissue of pre-obese fa/fa Zucker rats.
    Blouquit MF; Geloën A; Koubi H; Edwards D; Gripois D
    J Dev Physiol; 1993 Jun; 19(6):247-51. PubMed ID: 7963300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S; Patel PN
    Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
    Coe JW; Brooks PR; Vetelino MG; Wirtz MC; Arnold EP; Huang J; Sands SB; Davis TI; Lebel LA; Fox CB; Shrikhande A; Heym JH; Schaeffer E; Rollema H; Lu Y; Mansbach RS; Chambers LK; Rovetti CC; Schulz DW; Tingley FD; O'Neill BT
    J Med Chem; 2005 May; 48(10):3474-7. PubMed ID: 15887955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats.
    Goutier W; Kloeze MB; McCreary AC
    Addict Biol; 2015 Mar; 20(2):248-58. PubMed ID: 24251901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic action by neuropeptide Y (NPY) and norepinephrine (NE) on food intake, metabolic rate, and brown adipose tissue (BAT) causes remarkable weight loss in the obese (fa/fa) Zucker rat.
    al-Arabi A; Andrews JF
    Biomed Sci Instrum; 1997; 33():216-25. PubMed ID: 9731362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of varenicline for smoking cessation.
    Hays JT; Ebbert JO; Sood A
    Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local alpha-bungarotoxin-sensitive nicotinic receptors modulate hippocampal norepinephrine release by systemic nicotine.
    Fu Y; Matta SG; Sharp BM
    J Pharmacol Exp Ther; 1999 Apr; 289(1):133-9. PubMed ID: 10086996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice.
    Biala G; Staniak N
    Pharmacol Biochem Behav; 2010 Aug; 96(2):141-7. PubMed ID: 20451547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
    Rollema H; Wilson GG; Lee TC; Folgering JH; Flik G
    Neurochem Int; 2011 Jan; 58(1):78-84. PubMed ID: 21056607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.